Skip to main content
. 2023 Dec 8;3(6):549–564. doi: 10.1007/s43657-023-00136-8

Fig. 3.

Fig. 3

Performance of RIS in predicting TIME and prognosis in HCC patients. a Receiver operating characteristic curves of RIS in training cohort (EHBH cohort 1). b Testing cohort (EHBH cohort 3). c Kaplan–Meier analyses of overall survival of RIS in EHBH cohort 4. d Combined cohort. e Representative patients with immune-activated TIME and immunosuppressive TIME, along with their MRI images and CODEX images